FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease The FDA has approved the first – and only – treatment, a cell therapy, for macular telangiectasia type 2 (MacTel), a rare neurodegenerative disease that causes irreversible vision loss. The treatment, Encelto (revakinagene taroretcel-lwey), is an encapsulated cell therapy, developed by Neurotech Pharmaceuticals, that […]